Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012991991> ?p ?o ?g. }
- W3012991991 endingPage "1497" @default.
- W3012991991 startingPage "1497" @default.
- W3012991991 abstract "The design of multitarget drugs (MTDs) has become an innovative approach for the search of effective treatments in complex diseases such as cancer. In this work, we communicate our efforts in the design of multi-targeting histone deacetylase (HDAC) and protein kinase CK2 inhibitors as a novel therapeutic strategy against cancer. Using tetrabromobenzotriazole (TBB) and 2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole (DMAT) as scaffolds for CK2 inhibition, and a hydroxamate to coordinate the zinc atom present in the active site of HDAC (zinc binding group, ZBG), new multitarget inhibitors have been designed and synthesized. According to the in vitro assays, N-Hydroxy-6-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)hexanamide (11b) is the most interesting compound, with IC50 values of 0.66; 1.46 and 3.67 µM. for HDAC6; HDAC1 and CK2; respectively. Cellular assays on different cancer cell lines rendered promising results for N-Hydroxy-8-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)octanamide (11d). This inhibitor presented the highest cytotoxic activity, proapoptotic capability, and the best mitochondria-targeting and multidrug-circumventing properties, thus being the most promising drug candidate for further in vivo studies." @default.
- W3012991991 created "2020-04-03" @default.
- W3012991991 creator A5003528740 @default.
- W3012991991 creator A5013691561 @default.
- W3012991991 creator A5022479098 @default.
- W3012991991 creator A5043199638 @default.
- W3012991991 creator A5049587711 @default.
- W3012991991 creator A5054159721 @default.
- W3012991991 creator A5078225528 @default.
- W3012991991 creator A5084071049 @default.
- W3012991991 creator A5084716539 @default.
- W3012991991 creator A5085237177 @default.
- W3012991991 date "2020-03-25" @default.
- W3012991991 modified "2023-10-04" @default.
- W3012991991 title "Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors" @default.
- W3012991991 cites W1576011410 @default.
- W3012991991 cites W1579943541 @default.
- W3012991991 cites W1967089336 @default.
- W3012991991 cites W1969375092 @default.
- W3012991991 cites W1969543057 @default.
- W3012991991 cites W1970197743 @default.
- W3012991991 cites W1978047155 @default.
- W3012991991 cites W1981775239 @default.
- W3012991991 cites W1985515161 @default.
- W3012991991 cites W1987767964 @default.
- W3012991991 cites W1995751128 @default.
- W3012991991 cites W1996547558 @default.
- W3012991991 cites W1996715118 @default.
- W3012991991 cites W2003858378 @default.
- W3012991991 cites W2013434401 @default.
- W3012991991 cites W2016011980 @default.
- W3012991991 cites W2018257566 @default.
- W3012991991 cites W2020389231 @default.
- W3012991991 cites W2022285476 @default.
- W3012991991 cites W2028733293 @default.
- W3012991991 cites W2029148944 @default.
- W3012991991 cites W2031168104 @default.
- W3012991991 cites W2033433713 @default.
- W3012991991 cites W2038120798 @default.
- W3012991991 cites W2042232241 @default.
- W3012991991 cites W2046273918 @default.
- W3012991991 cites W2048959932 @default.
- W3012991991 cites W2057001017 @default.
- W3012991991 cites W2058479011 @default.
- W3012991991 cites W2058739448 @default.
- W3012991991 cites W2062817955 @default.
- W3012991991 cites W2063600933 @default.
- W3012991991 cites W2067174909 @default.
- W3012991991 cites W2067395908 @default.
- W3012991991 cites W2070272981 @default.
- W3012991991 cites W2073100055 @default.
- W3012991991 cites W2077605453 @default.
- W3012991991 cites W2082482473 @default.
- W3012991991 cites W2085173493 @default.
- W3012991991 cites W2091257276 @default.
- W3012991991 cites W2091616887 @default.
- W3012991991 cites W2092771170 @default.
- W3012991991 cites W2093153665 @default.
- W3012991991 cites W2093611899 @default.
- W3012991991 cites W2095510836 @default.
- W3012991991 cites W2096460391 @default.
- W3012991991 cites W2099803844 @default.
- W3012991991 cites W2102377211 @default.
- W3012991991 cites W2102650381 @default.
- W3012991991 cites W2103638131 @default.
- W3012991991 cites W2103980474 @default.
- W3012991991 cites W2108017291 @default.
- W3012991991 cites W2108805958 @default.
- W3012991991 cites W2112351720 @default.
- W3012991991 cites W2121723225 @default.
- W3012991991 cites W2125307493 @default.
- W3012991991 cites W2134682046 @default.
- W3012991991 cites W2136993685 @default.
- W3012991991 cites W2137147094 @default.
- W3012991991 cites W2138276393 @default.
- W3012991991 cites W2140595402 @default.
- W3012991991 cites W2156283242 @default.
- W3012991991 cites W2160842779 @default.
- W3012991991 cites W2166622998 @default.
- W3012991991 cites W2275563446 @default.
- W3012991991 cites W2314990578 @default.
- W3012991991 cites W2320230258 @default.
- W3012991991 cites W2323789217 @default.
- W3012991991 cites W2325550803 @default.
- W3012991991 cites W2327664374 @default.
- W3012991991 cites W2332712348 @default.
- W3012991991 cites W2404280981 @default.
- W3012991991 cites W2461836249 @default.
- W3012991991 cites W2499955277 @default.
- W3012991991 cites W2558586414 @default.
- W3012991991 cites W2581414232 @default.
- W3012991991 cites W2590525769 @default.
- W3012991991 cites W2593436234 @default.
- W3012991991 cites W2618890751 @default.
- W3012991991 cites W2685293566 @default.
- W3012991991 cites W2745222888 @default.
- W3012991991 cites W2746334444 @default.
- W3012991991 cites W2751600998 @default.